A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

Clinical trial NCT07733765 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07733765
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alopecia Areata

Start date: 2026-07-31
Primary completion: 2028-04-27
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.